CNIC | sciencenewsnet.in

Breaking News

Out of Africa: UT Southwestern cardiologist gets to the heart of Zambia’s No. 1 health threat

Researchers report first published case of a patient with treatment-emergent neuroendocrine prostate cancer who showed a remarkable response to an anti-HER2 antibody-drug conjugate

Weight loss interventions associated with improvements in several symptoms of PCOS

Policies assuring safe practice by late-career physicians vary widely among health care organizations

Patients outside metropolitan areas often travel significantly more than 20 minutes for primary care visit

Discovery of a protein’s key role in RNA processes could improve disease treatment in humans and plants

Health Research Launches Into Orbit to Discover How Spaceflight Affects Blood

Argonne to help drive AI revolution in astronomy with new institute led by Northwestern University

Gastrointestinal Surgeon Fabrizio Michelassi, MD, FACS, Elected Chair of ACS Board of Regents

UW–Madison researchers find persistent problems with AI-assisted genomic studies

05 Nov, 2024

Presence of Subclinical Atherosclerosis Is Marker of Mortality and Its Progression Increases Risk of Death

September 30, 2024 sarah JonasResearch Results

Mount Sinai study also shows imaging for early detection and monitoring can improve prediction and prevention of premature death

Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart

October 18, 2022 sarah JonasAnnouncement

Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named President of Mount Sinai Heart, a newly created position, effective Sunday, January 1, 2023. Dr. Fuster will continue in his roles as Physician-in-Chief of The Mount Sinai Hospital and as the Richard Gorlin, MD/Heart Research Foundation Professor at the Icahn School of Medicine at Mount Sinai.

“Polypill” Reduces Cardiovascular Mortality by 33 Percent in Patients Treated After a Heart Attack

August 26, 2022 sarah JonasResearch Results

A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.